Literature DB >> 4596671

The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients.

H A McClelland, G Blessed, S Bhate, N Ali, P A Clarke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4596671     DOI: 10.1192/bjp.124.2.151

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  10 in total

1.  Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.

Authors:  H A McClelland
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

Review 2.  Pharmacological treatment of patients with schizophrenia. Past and present problems and potential future therapy.

Authors:  D A Johnson
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

3.  Treatment of chronic schizophrenia.

Authors:  D A Johnson
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

4.  Adverse effects of antipsychotic agents.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

5.  Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Authors:  R J Hardie; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

6.  Anticholinergic drug abuse: a common problem?

Authors:  G P Pullen; N R Best; J Maguire
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-08

Review 7.  Drug treatment of resistant schizophrenia. Limitations and recommendations.

Authors:  A E Farmer; A Blewett
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 8.  Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia.

Authors:  M F Bristow; S R Hirsch
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 9.  Thioridazine for schizophrenia.

Authors:  M Fenton; J Rathbone; J Reilly; A Sultana
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

10.  A study of prophylactic value of antiparkinsonian drug.

Authors:  P B Behere; P Ramakrishna
Journal:  Indian J Psychiatry       Date:  1983-07       Impact factor: 1.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.